BioVaxys Technology Corp. C.BIOV

Alternate Symbol(s): BVAXF

Healthcare Biotechnology

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical-stage pipeline includes maveropepimut-S, which is in phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using its HapTenix neoantigen tumor cell construct platform for treating refractive late-stage ovarian cancer. The Company is also leveraging its expertise in tumor immunology by creating a unique library of T-lymphocytes and other datasets post-vaccination with its personalized immunotherapeutic vaccines to identify new targetable tumor antigens.

CSE:BIOV - Post by User

BioVaxys Technology Corp.

<< Previous

Bullboard Posts

Next >>

Post by frankmanon Dec 19, 2024 11:34am

29 Views

Post# 36370371

More .065 buying

Time ET	Ex	Price	Change	Volume	Buyer	Seller
11:17:59	M	0.065	0.005	2	7 TD Sec	7 TD Sec
10:59:05	O	0.065	0.005	5,000	80 National Bank	13 Instinet
10:59:05	O	0.065	0.005	30,000	80 National Bank	13 Instinet
10:59:05	O	0.065	0.005	10,000	80 National Bank	13 Instinet
10:59:05	O	0.065	0.005	5,000	80 National Bank	2 RBC
10:57:24	O	0.065	0.005	8,000	89 Raymond James	1 Anonymous
10:56:37	O	0.065	0.005	5,000	89 Raymond James	1 Anonymous
10:56:11	H	0.065	0.005	5,000	1 Anonymous	1 Anonymous